Regeneron Pharmaceuticals Inc.’s stock rose 4.9% Tuesday to put it on track for its biggest one-day gain in almost two years, ...

With a market cap of $77.3 billion, Regeneron Pharmaceuticals ... edge science to improve patient outcomes. The Tarrytown, New York-based company is expected to unveil its fiscal Q4 earnings ...

Silva in the complaint filed in the US District Court for the Southern District of New York. By not doing so, executives led Regeneron to be sued by ...

Your biospecimen will be sent to the Regeneron Genetics Center for genetic sequencing, then stored for future analysis. With something as sacred as your genetic material in its hands, Truveta and ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

AT&T has stopped offering its 5G home Internet service in New York instead of complying with a new state law that requires ISPs to offer $15 or $20 plans to people with low incomes. The decision ...

Investing.com -- UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 ...

Even before the ceasefire in Gaza Donald Trump had begun to reshape the Middle East. He was influential ... enough to fill New York’s Central Park to a depth of eight metres.

President-elect Trump's incoming Middle East envoy, Steve Witkoff ... Like Trump, Witkoff is originally from New York but moved to Florida in recent years. Trump and Witkoff are close friends.

NASHVILLE, Tenn. (WTVF) — The Tennessee Performing Arts Center is now on the move to look for a new home out of the proposed East Bank site on the edges of the Cumberland River. TPAC confirmed ...

Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition ...